Patient Information Leaflet
Melatonin Bluefish 2 mg prolonged-release tablets EFG
Read this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack:
The active substance of Melatonin Bluefish is melatonin and belongs to a group of natural hormones produced by the body.
Melatonin Bluefish is used on its own for the short-term treatment of primary insomnia (persistent difficulty falling asleep or staying asleep, or poor quality sleep) in patients aged 55 and over. "Primary" means that the insomnia has no identifiable cause, whether medical, mental, or environmental.
Do not take Melatonin Bluefish
Warnings and precautions
Consult your doctor or pharmacist before taking Melatonin Bluefish.
Children and adolescents
This medicine should not be given to children or adolescents from 0 to 18 years, as it has not been evaluated in this population and its effects are not known. For administration to children from 2 to 18 years, another melatonin medicine may be more suitable; consult your doctor or pharmacist.
Other medicines and Melatonin Bluefish
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines. These medicines include:
Taking Melatonin Bluefish with food, drinks, and alcohol
Take melatonin after you have eaten some food. Do not drink alcohol before, after, or during melatonin administration, as it reduces the effectiveness of the medicine.
Pregnancy and breastfeeding
If you are pregnant, think you may be pregnant, or plan to become pregnant. Consult your doctor or pharmacist before using this medicine.
Pregnancy
Melatonin is not recommended if you are pregnant or plan to have a baby. Melatonin crosses the placenta, and there is not enough information about the risk it may pose to the fetus.
Breastfeeding
Melatonin is not recommended if you are breastfeeding. Melatonin passes into breast milk, and the risk to breastfed children cannot be excluded.
Driving and using machines
Melatonin can cause drowsiness. In that case, do not drive or operate machinery. Consult your doctor if you experience continuous drowsiness.
Melatonin Bluefish contains lactose monohydrate
If your doctor has told you that you have an intolerance to certain sugars, consult them before taking this medicine.
Follow the administration instructions of this medicine exactly as indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.
The recommended dose is one tablet (2 mg) of melatonin per day, taken orally after eating some food, 1 or 2 hours before bedtime. This dose may be extended for a maximum of thirteen weeks.
Oral use. You should swallow the tablet whole to maintain its prolonged-release properties. Do not crush or chew to facilitate swallowing.
If you take more Melatonin Bluefish than you should
If you accidentally take more medicine than you should, go to your doctor or pharmacist as soon as possible.
Taking a higher dose than recommended per day may cause drowsiness.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount taken.
If you forget to take Melatonin Bluefish
If you forget to take the tablet, take it as soon as you remember, before bedtime, or wait until the next dose and then continue as before.
Do not take a double dose to make up for forgotten doses.
If you stop taking Melatonin Bluefish
Stopping or prematurely ending treatment does not cause any known harmful effects. The use of melatonin does not cause withdrawal effects after treatment ends.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If you experience any of the following serious side effects, stop taking the medicine and contact your doctor immediately:
Uncommon: (may affect up to 1 in 100 people)
Rare: (may affect up to 1 in 1,000 people)
If you experience any of the following non-serious side effects, contact your doctor or seek medical attention:
Uncommon: (may affect up to 1 in 100 people)
Rare: (may affect up to 1 in 1,000 people)
Frequency not known: (cannot be estimated from the available data)
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report them directly through the Spanish Medicines Agency's website www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the pack after (EXP). The expiry date is the last day of the month stated.
This medicine does not require any special storage conditions.
Medicines should not be disposed of via wastewater or household waste. Return the containers and any unused medicines to the pharmacy. If in doubt, ask your pharmacist how to dispose of the containers and any unused medicines. This will help protect the environment.
Composition of Melatonin Bluefish
Appearance and packaging
The prolonged-release tablets are white to off-white, round, biconvex, and 8 mm in diameter. The tablets are not coated and are smooth on both sides.
The tablets are packaged in PVC/PE/PVDC-Aluminum blisters.
Pack size: 30 tablets.
Marketing authorization holder and manufacturer
Marketing authorization holder
Bluefish Pharmaceuticals AB
P.O. Box 49013,
100 28 Stockholm
Sweden
Manufacturer
Bluefish Pharmaceuticals AB
Gävlegatan 22
113 30 Stockholm
Sweden
or
Misom Labs Ltd.
Malta Life Sciences Park
LS2.01.06 Industrial Estate
San Gwann
SGN 3000
Malta
This medicine is authorized in the Member States of the European Economic Area under the following names:
Germany | Melatonin Bluefish 2 mg Retardtabletten |
Austria | Melatonin Bluefish 2 mg Retardtabletten |
Denmark | Melatonin Bluefish |
Spain | Melatonina Bluefish 2 mg comprimidos de liberación prolongada EFG |
France | Melatonine Bluefish LP 2 mg, comprimé à libération prolongée |
Iceland | Melatonin Bluefish 2 mg forðatöflur |
Norway | Melatonin Bluefish 2 mg depottabletter |
Portugal | Melatonina Bluefish 2 mg comprimidos de libertação prolongada |
United Kingdom (NI) | Melatonin Bluefish 2 mg prolonged-release tablets |
Sweden | Melatonin Bluefish |
Date of last revision of this leaflet:December 2024
Other sources of information
Detailed and up-to-date information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es